JOHNSON & Johnson is recalling
some vials of Risperdal Consta in
the US over concerns about mould
contamination of the product.
A spokesperson said that routine
analysis of one batch of the
injectable schizophrenia therapy
has shown the presence of the
mould Alternaria alternata.
She said there had not been
any trends of adverse events
associated with the batch which
was manufactured last year.
The move followed another
recall last week by J&J’s McNeil
Consumer Healthcare Division of
about 200,000 bottles of Motrin
Infants’ Drops due to possible
plastic particle contamination.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 13
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.